• SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc.(SLRN) of a Class Action Lawsuit and an Upcoming Deadli... ACCESS Newswire Fri, 04 Jul 2025 06:06:41 GMT
• shareholder alert: levi & korsinsky reminds shareholders of a lead plaintiff deadline of january 16, 2024 in acelyrin lawsuit - sl... ACCESS Newswire Thu, 03 Jul 2025 22:17:29 GMT
• acelyrin requests to dismiss class action filed by investors TradingView Fri, 13 Jun 2025 15:59:15 GMT
• shareholder alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff dea... ACCESS Newswire Tue, 10 Jun 2025 14:08:25 GMT
• guggenheim raises alumis stock to buy with $18 price target by investing.com Investing.com South Africa Tue, 10 Jun 2025 13:59:41 GMT
• shareholder alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff dea... ACCESS Newswire Sat, 07 Jun 2025 18:32:15 GMT
• investor alert: levi & korsinsky reminds shareholders of a lead plaintiff deadline of january 16, 2024 in acelyrin lawsuit - slrn ACCESS Newswire Thu, 05 Jun 2025 13:38:02 GMT
• Kalkine: Acelyrin’s Shareholdings Within Key Market Indexes Top Companies in the NASDAQ Kalkine Kalkine Media Wed, 04 Jun 2025 07:00:00 GMT
• Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT Insider Monkey Mon, 02 Jun 2025 07:00:00 GMT
• northern trust corp grows position in acelyrin, inc. (nasdaq:slrn) Defense World Mon, 26 May 2025 07:00:00 GMT
• acelyrin, inc.(nasdaqgs: slrn) dropped from s&p tmi index marketscreener.com Fri, 23 May 2025 01:05:28 GMT
• acelyrin, inc.(nasdaqgs: slrn) dropped from s&p global bmi index marketscreener.com Fri, 23 May 2025 01:05:25 GMT
• acelyrin, inc.(nasdaqgs: slrn) dropped from s&p tmi index MarketScreener Thu, 22 May 2025 07:00:00 GMT
• acelyrin, inc.(nasdaqgs: slrn) dropped from s&p global bmi index marketscreener.com Thu, 22 May 2025 07:00:00 GMT
• alumis completes merger with acelyrin, extends cash runway by investing.com Investing.com Canada Thu, 22 May 2025 01:31:13 GMT
• Alumis Inc. Completes Merger with ACELYRIN, Inc. to Strengthen Pipeline in Immune-Mediated Disease Therapies Nasdaq Wed, 21 May 2025 07:00:00 GMT
• Alumis-ACELYRIN Merger Creates Powerhouse in Immune Disease Drug Development with 2027 Cash Runway Stock Titan Wed, 21 May 2025 07:00:00 GMT
• Alumis Completes Merger With ACELYRIN, Strengthens Pipeline And Cash Runway Nasdaq Wed, 21 May 2025 07:00:00 GMT
• Alumis completes merger with ACELYRIN, extends cash runway Investing.com Wed, 21 May 2025 07:00:00 GMT
• dimensional fund advisors lp buys new shares in acelyrin, inc. (nasdaq:slrn) Defense World Sat, 17 May 2025 08:10:40 GMT
• alumis reports first quarter 2025 financial results and highlights recent achievements The Manila Times Thu, 15 May 2025 07:00:00 GMT
• Alumis' Acelyrin merger back on track after shareholders unswayed by activist investor Fierce Biotech Wed, 14 May 2025 07:00:00 GMT
• Merger roundup: bluebird purchase terms adjusted, Alumis agrees to Acelyrin deal FirstWord Pharma Wed, 14 May 2025 07:00:00 GMT
• ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Comm... The Manila Times Wed, 14 May 2025 07:00:00 GMT
• Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements The Globe and Mail Wed, 14 May 2025 07:00:00 GMT
• alumis inc. reports first quarter 2025 financial results TradingView Wed, 14 May 2025 07:00:00 GMT
• alumis wins shareholder nod for acelyrin merger by investing.com Investing.com Nigeria Tue, 13 May 2025 17:03:45 GMT
• acelyrin (slrn) stockholders approve merger with alumis (alms) StreetInsider Tue, 13 May 2025 17:01:17 GMT
• hsbc holdings plc makes new $36,000 investment in acelyrin, inc. (nasdaq:slrn) Defense World Tue, 13 May 2025 07:27:36 GMT
• ACELYRIN-Alumis Merger Gets Green Light: New Powerhouse in Immune Disease Treatment Emerges Stock Titan Tue, 13 May 2025 07:00:00 GMT
• How a Peninsula biotech's merger drama overcame several investor headaches The Business Journals Tue, 13 May 2025 07:00:00 GMT
• acelyrin, inc. stockholders approve merger agreement with alumis inc. Nasdaq Tue, 13 May 2025 07:00:00 GMT
• alumis-acelyrin merger gets green light: major breakthrough for immune disease treatment pipeline Stock Titan Tue, 13 May 2025 07:00:00 GMT
• acelyrin stockholders approve merger with alumis to create clinical biopharma company dedicated to innovating, developing and comm... Yahoo Finance Tue, 13 May 2025 07:00:00 GMT
• acelyrin shareholders approve alumis merger deal by investing.com Investing.com India Tue, 13 May 2025 07:00:00 GMT
• barclays plc increases stock position in acelyrin, inc. (nasdaq:slrn) Defense World Sun, 11 May 2025 08:34:51 GMT
• wells fargo & company mn grows holdings in acelyrin, inc. (nasdaq:slrn) Defense World Sat, 10 May 2025 07:00:00 GMT
• wex, acelyrin, and more stocks see action from activist investors MSN Sat, 10 May 2025 06:32:22 GMT
• investor alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop - levi & korsinsky pursuing class ac... ACCESS Newswire Fri, 09 May 2025 10:16:05 GMT
• leading independent proxy advisory firm iss recommends acelyrin stockholders vote “for” the proposed transaction with alumis Yahoo Finance Tue, 06 May 2025 07:00:00 GMT
• acelyrin encourages stockholders to support merger with alumis inc. following iss recommendation Nasdaq Tue, 06 May 2025 07:00:00 GMT
• shareholder alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop - levi & korsinsky pursuing class... ACCESS Newswire Sat, 03 May 2025 16:20:07 GMT
• shareholder alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff dea... ACCESS Newswire Sat, 03 May 2025 15:59:54 GMT
• SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc. (SLRN) of a Class Action Lawsuit and an Upcoming Deadl... ACCESS Newswire Fri, 02 May 2025 23:41:35 GMT
• acelyrin urges stockholders to vote for proposed merger with alumis Yahoo Finance Fri, 02 May 2025 07:00:00 GMT
• ACELYRIN Board Makes Final Push for Alumis Merger: 48% Ownership Deal at Stake in Critical May Vote Stock Titan Thu, 01 May 2025 07:00:00 GMT
• acelyrin, inc. urges stockholders to vote in favor of proposed merger with alumis inc. ahead of may 13, 2025 meeting Nasdaq Thu, 01 May 2025 07:00:00 GMT
• acelyrin reiterates benefits of value-maximizing combination with alumis Yahoo Finance Thu, 01 May 2025 07:00:00 GMT
• acelyrin urges stockholders to vote for proposed merger with alumis TipRanks Thu, 01 May 2025 07:00:00 GMT
• Investor pressures Acelyrin to exit Alumis merger and liquidate, slams ‘inexplicable’ process Fierce Biotech Wed, 30 Apr 2025 07:00:00 GMT
• Major Shareholder Opposes Acelyrin’s Merger With Alumis, Prefers Wind-Down BioSpace Wed, 30 Apr 2025 07:00:00 GMT
• madison avenue announces its intention to vote against acelyrin?s merger with alumis marketscreener.com Wed, 30 Apr 2025 07:00:00 GMT
• confident outlook on acelyrin-alumis merger amid shareholder opposition TipRanks Wed, 30 Apr 2025 07:00:00 GMT
• acelyrin (slrn) faces shareholder opposition to alumis merger GuruFocus Tue, 29 Apr 2025 22:30:00 GMT
• Acelyrin should liquidate instead of merging with Alumis, investor says BioPharma Dive Tue, 29 Apr 2025 07:00:00 GMT
• Acelyrin stock gains as Trium rebuffs M&A deal (SLRN:NASDAQ) Seeking Alpha Tue, 29 Apr 2025 07:00:00 GMT
• investor alert: levi & korsinsky notifies shareholders of acelyrin, inc. (slrn) of a class action lawsuit and an upcoming deadline... ACCESS Newswire Mon, 28 Apr 2025 22:19:29 GMT
• shareholder alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff dea... ACCESS Newswire Mon, 28 Apr 2025 21:18:19 GMT
• investor alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff deadli... ACCESS Newswire Mon, 28 Apr 2025 21:15:46 GMT
• bank of montreal can cuts stock holdings in acelyrin, inc. (nasdaq:slrn) Defense World Sun, 27 Apr 2025 07:00:00 GMT
• acelyrin, inc. reports third quarter 2024 financial results and recent highlights ADVFN Sat, 26 Apr 2025 03:25:02 GMT
• jpmorgan chase & co. sells 232,534 shares of acelyrin, inc. (nasdaq:slrn) Defense World Fri, 25 Apr 2025 07:20:36 GMT
• Alumis and Acelyrin finalise amended merger agreement with improved terms World Pharmaceutical Frontiers Tue, 22 Apr 2025 07:00:00 GMT
• Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms Endpoints News Tue, 22 Apr 2025 07:00:00 GMT
• Revised merger terms boost ACELYRIN stake in Alumis deal Investing.com Mon, 21 Apr 2025 07:00:00 GMT
• $737 million deal reshapes immunology sector: inside alumis and acelyrin's strategic merger revolution Stock Titan Mon, 21 Apr 2025 07:00:00 GMT
• alumis secures major immunology merger: $737m cash runway stretches to 2027, 62% shareholders back deal Stock Titan Mon, 21 Apr 2025 07:00:00 GMT
• alumis and acelyrin announce amended merger agreement MarketScreener Mon, 21 Apr 2025 07:00:00 GMT
• alumis raises share consideration for acelyrin acquisition marketscreener.com Mon, 21 Apr 2025 07:00:00 GMT
• acelyrin and alumis announce revised merger agreement enhancing stockholder ownership and value Nasdaq Mon, 21 Apr 2025 07:00:00 GMT
• 3 value stocks to buy amid trump’s tariff turmoil, 4/17/2025, according to analysts The Globe and Mail Thu, 17 Apr 2025 15:48:00 GMT
• wheat pushing higher ahead of export sales release The Globe and Mail Thu, 17 Apr 2025 12:32:00 GMT
• ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Pro... Business Wire Wed, 16 Apr 2025 07:00:00 GMT
• ACELYRIN Optimizes the Sponsor-CRO Data Flow with a Centralized Clinical Data Workbench Veeva Wed, 09 Apr 2025 01:47:07 GMT
• Alumis and Acelyrin file a definitive proxy statement for proposed merger Ophthalmology Times Mon, 07 Apr 2025 07:00:00 GMT
• ssi weekly newsletter: updates on liquidia, springworks, allakos, acelyrin, saga, nzme, nathan’s, hillevax, ttec Smartkarma Sun, 06 Apr 2025 01:28:21 GMT
• alumis and acelyrin file joint definitive proxy statement for proposed merger The Manila Times Sat, 05 Apr 2025 07:00:00 GMT
• $hareholder alert: the m&a class action firm continues to investigate the merger – optn, slrn, akya, shyf TradingView Fri, 04 Apr 2025 23:00:00 GMT
• Major Biopharma Merger: Alumis and ACELYRIN Unite with $737M War Chest for Immune Disease Breakthroughs Stock Titan Fri, 04 Apr 2025 07:00:00 GMT
• alumis and acelyrin file joint definitive proxy statement for proposed merger The Globe and Mail Fri, 04 Apr 2025 07:00:00 GMT
• Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts Fierce Biotech Wed, 02 Apr 2025 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates amps, becn, slrn, alms on behalf of shareholders The Malaysian Reserve Tue, 01 Apr 2025 15:10:29 GMT
• alumis, acelyrin merger deal nearly upended by last-minute offer - san francisco business times The Business Journals Fri, 28 Mar 2025 14:56:00 GMT
• last-minute suitor nearly upends biotech merger The Business Journals Fri, 28 Mar 2025 14:56:00 GMT
• Before Alumis went public via IPO, it tried doing a reverse merger with Acelyrin Endpoints News Fri, 28 Mar 2025 07:00:00 GMT
• last-minute suitor nearly upends alumis, acelyrin merger The Business Journals Fri, 28 Mar 2025 07:00:00 GMT
• $hareholder alert: the m&a class action firm continues to investigate the merger – slrn, turn, bhlb, mhld TradingView Thu, 27 Mar 2025 07:00:00 GMT
• acelyrin sees stock price rise amid rights plan Los Angeles Business Journal Tue, 25 Mar 2025 07:00:00 GMT
• Acelyrin Sees Stock Price Rise Amid Rights Plan Los Angeles Business Journal Mon, 24 Mar 2025 07:00:00 GMT
• acelyrin stock plunges after positive phase ii data readout in thyroid eye disease MSN Sat, 22 Mar 2025 21:34:11 GMT
• tang capital management llc increases stake in acelyrin inc GuruFocus Fri, 21 Mar 2025 07:00:00 GMT
• acelyrin inc reports results for the quarter ended december 31 - earnings summary TradingView Thu, 20 Mar 2025 07:00:00 GMT
• acelyrin’s chief legal officer murugan amar sells $10,737 in stock by investing.com Investing.com South Africa Thu, 20 Mar 2025 01:44:35 GMT
• alumis reports year end 2024 financial results and highlights recent achievements The Manila Times Wed, 19 Mar 2025 20:11:28 GMT
• acelyrin stock plunges after positive phase ii data readout in thyroid eye disease MSN Wed, 19 Mar 2025 19:13:44 GMT
• Alumis Doubles R&D Investment, Secures Game-Changing Merger Worth $737M Stock Titan Wed, 19 Mar 2025 07:00:00 GMT
• acelyrin ceo kim mina sells $49,353 in company stock by investing.com Investing.com Nigeria Wed, 19 Mar 2025 07:00:00 GMT
• alumis inc. reports phase 2 and phase 1 clinical data, announces merger agreement with acelyrin, and highlights 2024 financial res... Nasdaq Wed, 19 Mar 2025 07:00:00 GMT
• acelyrin chief medical officer mpofu shephard sells $8,810 in stock Investing.com Wed, 19 Mar 2025 07:00:00 GMT
• acelyrin’s chief legal officer murugan amar sells $10,737 in stock Investing.com Wed, 19 Mar 2025 07:00:00 GMT
• acelyrin executives sell shares to cover tax obligations TradingView Wed, 19 Mar 2025 07:00:00 GMT
• Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now Yahoo Finance Tue, 18 Mar 2025 07:00:00 GMT
• 10 best short-term stocks to buy now with rebound potential Insider Monkey Sun, 16 Mar 2025 05:04:16 GMT
• pliant, acelyrin take ‘poison pills’ as concentra buyout looms Fierce Biotech Fri, 14 Mar 2025 14:01:00 GMT
• Pliant, Acelyrin resort to ‘poison pills’ as threat of Concentra buyout looms Fierce Biotech Fri, 14 Mar 2025 07:00:00 GMT
• Makary advances to full senate vote; Acelyrin, Pliant adopt ‘poison pills’ BioPharma Dive Fri, 14 Mar 2025 07:00:00 GMT
• acelyrin adopts rights plan in response to tang capital stake by investing.com Investing.com Australia Fri, 14 Mar 2025 03:27:23 GMT
• acelyrin adopts poison pill as tang capital partners raises stake MSN Thu, 13 Mar 2025 19:42:19 GMT
• acelyrin adopts stockholder rights plan; shares up pre-bell -march 13, 2025 at 08:09 am edt Marketscreener.com Thu, 13 Mar 2025 12:17:26 GMT
• Drug developers Pliant and Acelyrin adopt poison pill provisions to fend off activist investor The Business Journals Thu, 13 Mar 2025 07:00:00 GMT
• acelyrin stock in focus after poison pill (slrn:nasdaq) Seeking Alpha Thu, 13 Mar 2025 07:00:00 GMT
• acelyrin's defensive move: new rights plan blocks hostile takeover after major stake purchase Stock Titan Thu, 13 Mar 2025 07:00:00 GMT
• acelyrin adopts rights plan in response to tang capital stake Investing.com Thu, 13 Mar 2025 07:00:00 GMT
• acelyrin adopts limited-duration stockholder rights plan The Manila Times Thu, 13 Mar 2025 07:00:00 GMT
• acelyrin, pliant turn to ‘poison pill’ as kevin tang’s concentra pursues both companies Endpoints News Thu, 13 Mar 2025 07:00:00 GMT
• acelyrin: potential buyout led by concentra biosciences (nasdaq:slrn) Seeking Alpha Wed, 12 Mar 2025 07:00:00 GMT
• How a skin drug trial could help Peninsula biotech pull off key merger The Business Journals Mon, 10 Mar 2025 07:00:00 GMT
• AAD25: Ahead of Acelyrin merger, Alumis flexes mid-stage data for oral TYK2 inhibitor in psoriasis FirstWord Pharma Sat, 08 Mar 2025 08:00:00 GMT
• acelyrin, alumis reaffirm strategic, financial rationale of proposed merger TipRanks Fri, 07 Mar 2025 08:42:02 GMT
• new york state common retirement fund lowers position in acelyrin, inc. (nasdaq:slrn) Defense World Fri, 07 Mar 2025 08:40:24 GMT
• Is Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now? Yahoo Finance Fri, 07 Mar 2025 08:00:00 GMT
• acelyrin and alumis merger faces activist challenges amid tang's higher offer and market skepticism Smartkarma Fri, 07 Mar 2025 08:00:00 GMT
• Acelyrin Rejects Concentra’s Buyout Offer in Favor of Alumis Merger BioSpace Wed, 05 Mar 2025 08:00:00 GMT
• Acelyrin rebuffs Concentra bid, believing Alumis option better The Pharma Letter Wed, 05 Mar 2025 08:00:00 GMT
• acelyrin reaffirms merger deal with alumis -march 04, 2025 at 10:13 am est Marketscreener.com Tue, 04 Mar 2025 15:15:59 GMT
• Acelyrin doubles down on Alumis merger after deciding Concentra's surprise offer 'not superior' Fierce Biotech Tue, 04 Mar 2025 08:00:00 GMT
• Acelyrin rebuffs Concentra, stands firm on Alumis merger FirstWord Pharma Tue, 04 Mar 2025 08:00:00 GMT
• Why ACELYRIN Turned Down Concentra's Offer to Stick With Alumis Merger Stock Titan Tue, 04 Mar 2025 08:00:00 GMT
• Acelyrin rejects buyout offer from Tang’s Concentra, sticks to Alumis merger Endpoints News Tue, 04 Mar 2025 08:00:00 GMT
• ACELYRIN, INC. and Alumis Inc. Announce Merger to Create Leading Clinical Stage Biopharma Company in Immune-Mediated Diseases Nasdaq Tue, 04 Mar 2025 08:00:00 GMT
• Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data BioPharma Dive Tue, 04 Mar 2025 08:00:00 GMT
• Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger The Manila Times Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin to proceed with alumis merger, spurn concentra bid insights.citeline.com Tue, 04 Mar 2025 08:00:00 GMT
• alumis inc. and acelyrin, inc. confirm commitment to all-stock merger to create leading biopharma company in immune-mediated disea... Nasdaq Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin stock falls on acelyrin deal commitment (slrn:nasdaq) Seeking Alpha Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin and alumis reaffirm strategic and financial rationale of proposed merger Yahoo Finance Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin, inc. reaffirms commitment to merger with alumis inc., rejects unsolicited proposal from concentra biosciences Nasdaq Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin slides after reiterating merger with alumis amid concentra's buyout offer TradingView Tue, 04 Mar 2025 08:00:00 GMT
• can acelyrin's $737m war chest transform immune disease treatment following alumis merger? Stock Titan Tue, 04 Mar 2025 08:00:00 GMT
• can this biopharma merger's $737m war chest transform immune disease treatment? Stock Titan Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin determines unsolicited indication of interest from concentra biosciences not reasonably expected to result in a superior ... Yahoo Finance Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin says concentra indication not expected to result in superior proposal TipRanks Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin, alumis reaffirm strategic, financial rationale of proposed merger TipRanks Tue, 04 Mar 2025 08:00:00 GMT
• sector update: health care stocks lower tuesday afternoon TradingView Tue, 04 Mar 2025 08:00:00 GMT
• acelyrin stock down after reaffirming alumis deal (slrn:nasdaq) Seeking Alpha Tue, 04 Mar 2025 08:00:00 GMT
• shareholder alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop - levi & korsinsky pursuing class... ACCESS Newswire Mon, 03 Mar 2025 11:44:04 GMT
• investor alert: levi & korsinsky notifies acelyrin, inc. investors of a class action lawsuit and upcoming deadline - slrn ACCESS Newswire Sun, 02 Mar 2025 18:52:08 GMT
• investor alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff deadli... ACCESS Newswire Sun, 02 Mar 2025 17:50:12 GMT
• shareholder alert: levi & korsinsky reminds shareholders of a lead plaintiff deadline of january 16, 2024 in acelyrin lawsuit - sl... ACCESS Newswire Sun, 02 Mar 2025 14:06:26 GMT
• shareholder alert: levi & korsinsky notifies shareholders of acelyrin, inc.(slrn) of a class action lawsuit and an upcoming deadli... ACCESS Newswire Sun, 02 Mar 2025 09:57:11 GMT
• shareholder alert: levi & korsinsky notifies shareholders of acelyrin, inc. (slrn) of a class action lawsuit and an upcoming deadl... ACCESS Newswire Sat, 01 Mar 2025 02:26:06 GMT
• shareholder alert: levi & korsinsky reminds acelyrin, inc. investors of the pending class action lawsuit with a lead plaintiff dea... ACCESS Newswire Fri, 28 Feb 2025 11:48:50 GMT
• shareholder alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop - levi & korsinsky pursuing class... ACCESS Newswire Fri, 28 Feb 2025 05:00:24 GMT
• shareholder alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop - levi & korsinsky pursuing class... ACCESS Newswire Thu, 27 Feb 2025 21:38:57 GMT
• investor alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop - levi & korsinsky pursuing class ac... ACCESS Newswire Wed, 26 Feb 2025 19:07:13 GMT
• shareholder alert: levi & korsinsky notifies shareholders of acelyrin, inc. (slrn) of a class action lawsuit and an upcoming deadl... ACCESS Newswire Tue, 25 Feb 2025 15:00:13 GMT
• counteroffer from tang-backed concentra could scuttle acelyrin-alumis: deals report BioCentury Tue, 25 Feb 2025 02:55:00 GMT
• top 5 biotech stocks that saw biggest retail following jump last week MSN Mon, 24 Feb 2025 03:38:20 GMT
• shareholder alert: potential recovery for acelyrin, inc. (slrn) investors affected by stock drop – levi & korsinsky pursuing class... ACCESS Newswire Sat, 22 Feb 2025 13:33:12 GMT
• concentra offers to buy acelyrin, endangering proposed merger with alumis BioSpace Fri, 21 Feb 2025 14:17:12 GMT
• concentra biosciences, llc made an unsolicited indication of interest to acquire acelyrin, inc. from a group of shareholders for a... Marketscreener.com Fri, 21 Feb 2025 13:55:59 GMT
• acelyrin jumps 11% on acquisition offer from concentra biosciences MSN Fri, 21 Feb 2025 11:08:20 GMT
• Concentra curveball offer throws Acelyrin merger with Alumis into doubt Fierce Biotech Fri, 21 Feb 2025 08:00:00 GMT
• Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair BioPharma Dive Fri, 21 Feb 2025 08:00:00 GMT
• Activist investor threatens Peninsula drug maker's merger plans The Business Journals Fri, 21 Feb 2025 08:00:00 GMT
• ACELYRIN shares surge on buyout interest By Investing.com Investing.com Nigeria Fri, 21 Feb 2025 08:00:00 GMT
• activist investor threatens drug maker's merger plans with l.a. biotech The Business Journals Fri, 21 Feb 2025 08:00:00 GMT
• acelyrin receives unsolicited buyout offer from concentra biosciences -february 21, 2025 at 04:38 am est Marketscreener.com Fri, 21 Feb 2025 08:00:00 GMT
• acelyrin confirms unsolicited indication of interest from concentra biosciences TipRanks Fri, 21 Feb 2025 02:43:09 GMT
• acelyrin, inc. confirms unsolicited acquisition proposal from concentra biosciences amidst ongoing merger agreement with alumis in... Nasdaq Fri, 21 Feb 2025 02:10:00 GMT
• can this new cash offer derail acelyrin's planned alumis merger? StockTitan Fri, 21 Feb 2025 02:03:11 GMT
• acelyrin confirms receipt of unsolicited indication of interest from concentra biosciences TradingView Fri, 21 Feb 2025 02:00:00 GMT
• Acelyrin, Inc. Confirms Unsolicited Acquisition Proposal from Concentra Biosciences Amidst Ongoing Merger Agreement with Alumis In... Nasdaq Thu, 20 Feb 2025 08:00:00 GMT
• can this new cash offer derail acelyrin's planned alumis merger? Stock Titan Thu, 20 Feb 2025 08:00:00 GMT
• acelyrin confirms receipt of unsolicited indication of interest from concentra biosciences Yahoo Finance Thu, 20 Feb 2025 08:00:00 GMT
• acelyrin confirms unsolicited indication of interest from concentra biosciences TipRanks Thu, 20 Feb 2025 08:00:00 GMT
• kuehn law encourages hees, slrn, ptmn, and ipg investors to contact law firm TradingView Tue, 18 Feb 2025 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates turn, amps, slrn on behalf of shareholders Stockhouse Publishing Thu, 13 Feb 2025 18:17:00 GMT
• h.c. wainwright cuts alumis stock target to $19, maintains buy rating MSN Wed, 12 Feb 2025 00:04:56 GMT
• h.c. wainwright cuts alumis stock target to $19, maintains buy rating MSN Tue, 11 Feb 2025 18:04:50 GMT
• slrn stock touches 52-week low at $1.85 amid market challenges Investing.com Tue, 11 Feb 2025 16:37:16 GMT
• after stumbles along winding path, acelyrin merges with alumis: deals report biocentury.com Tue, 11 Feb 2025 08:00:00 GMT
• kuehn law encourages nvro, slrn, tgi, and ptmn investors to contact law firm The Malaysian Reserve Mon, 10 Feb 2025 22:28:00 GMT
• shareholder investigation: halper sadeh llc investigates nvro, slrn, plya on behalf of shareholders Finansavisen Mon, 10 Feb 2025 17:03:00 GMT
• h.c. wainwright cuts alumis stock target to $19, maintains buy rating MSN Mon, 10 Feb 2025 08:31:05 GMT
• acelyrin investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and pro... Business Wire Mon, 10 Feb 2025 08:00:00 GMT
• the week in pharma: action, reaction and insight – week to february 7 | pharmaceutical | the pharmaletter The Pharma Letter Sun, 09 Feb 2025 08:00:00 GMT
• h.c. wainwright cuts alumis stock target to $19, maintains buy rating MSN Sun, 09 Feb 2025 00:27:42 GMT
• h.c. wainwright cuts alumis stock target to $19, maintains buy rating MSN Sat, 08 Feb 2025 14:00:26 GMT
• alert: rowley law pllc is investigating proposed acquisition of acelyrin, inc. PrimePublishers.com Fri, 07 Feb 2025 20:22:00 GMT
• Alumis and Acelyrin sign agreement to merge Pharmaceutical Technology Fri, 07 Feb 2025 08:00:00 GMT
Acelyrin Inc(NASDAQ:SLRN) 
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company is headquartered in Agoura Hills, California.
Website: https://acelyrin.com/
Founded: 2020
IPO Price: $18 (May 05, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends